Basic and clinical studies of S-1108 in the field of obstetrics and gynecology

Basic and clinical studies were performed, and the following results were obtained. S-1108, a new oral cephem antibiotic, was evaluated for its tissue concentration in female genital organs after administration of 100 and 200 mg doses (n=10). The peak serum levels in uterine artery and cubital vein...

Full description

Saved in:
Bibliographic Details
Published inCHEMOTHERAPY Vol. 41; no. Supplement1; pp. 589 - 593
Main Authors Matsuda, Seiji, Oh, Kinki, Hirayama, Hiroaki
Format Journal Article
LanguageJapanese
Published Japanese Society of Chemotherapy 30.06.1993
Online AccessGet full text

Cover

Loading…
Abstract Basic and clinical studies were performed, and the following results were obtained. S-1108, a new oral cephem antibiotic, was evaluated for its tissue concentration in female genital organs after administration of 100 and 200 mg doses (n=10). The peak serum levels in uterine artery and cubital vein blood were 0.34μg/ml at 3 hours after the 100 mg dose, while genital tissue levels were 0.06-0.18μg/g. After administration of 200mg, serum levels and genital tissue levels were 0.24-0.44μg/ml and 0.12-0.17μg/g respectively at 4 hours. In clinical studies, S-1108 was administered to 9 patients (endometritis: 2, bartholinitis: 1, abscess of bartholin: 1, mastitis: 4, abscess of genitals: 1). The daily dose was 100mg three times a day. The total clinical efficacy rate was 8/9, and the bacteriological effect showed all organisms isolated (5 strains) eradicated after treatment. No serious adverse effects were observed in any of the cases.
AbstractList Basic and clinical studies were performed, and the following results were obtained. S-1108, a new oral cephem antibiotic, was evaluated for its tissue concentration in female genital organs after administration of 100 and 200 mg doses (n=10). The peak serum levels in uterine artery and cubital vein blood were 0.34μg/ml at 3 hours after the 100 mg dose, while genital tissue levels were 0.06-0.18μg/g. After administration of 200mg, serum levels and genital tissue levels were 0.24-0.44μg/ml and 0.12-0.17μg/g respectively at 4 hours. In clinical studies, S-1108 was administered to 9 patients (endometritis: 2, bartholinitis: 1, abscess of bartholin: 1, mastitis: 4, abscess of genitals: 1). The daily dose was 100mg three times a day. The total clinical efficacy rate was 8/9, and the bacteriological effect showed all organisms isolated (5 strains) eradicated after treatment. No serious adverse effects were observed in any of the cases.
Author Matsuda, Seiji
Oh, Kinki
Hirayama, Hiroaki
Author_xml – sequence: 1
  fullname: Matsuda, Seiji
  organization: Department of Obstetrics and Gynecology, Koto Hospital
– sequence: 2
  fullname: Oh, Kinki
  organization: Department of Obstetrics and Gynecology, Koto Hospital
– sequence: 3
  fullname: Hirayama, Hiroaki
  organization: Department of Obstetrics and Gynecology, Koto Hospital
BookMark eNpdkMlOwzAURS1UJErpP_gDSPCY2EuomKQKFu3eOM5L6yp1othd5O8Jw6Lq6t033Pukc4tmoQuA0D0lOaVMkge3h2OX9jDYfqRa8lzQfHPq-xaOEBI1UukrNKdKiWySYobmhBCdcVrIG7SM0VeEUEoKptgcfTzZ6B22ocau9cE72-KYTrWHiLsGb7LpUmEf8PQQNx7a-mfcVTFBGryLv87dGMB1bbcb79B1Y9sIy_-6QNuX5-3qLVt_vr6vHtfZgYoiZKK2hWyq0sma6YLrgnDLS8UJsVqBkqXUGkAUotIlLy1jTjnZaCY4qaYNX6Cvv9hDTHYHph_80Q6jsUPyrgVzicgIas4RXbQTpjOrHQwE_g2l63Fl
ContentType Journal Article
Copyright Japanese Society of Chemotherapy
Copyright_xml – notice: Japanese Society of Chemotherapy
DOI 10.11250/chemotherapy1953.41.Supplement1_589
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
EISSN 1884-5894
EndPage 593
ExternalDocumentID article_chemotherapy1953_41_Supplement1_41_Supplement1_589_article_char_en
GroupedDBID 53G
AAUGY
ADBBV
ALMA_UNASSIGNED_HOLDINGS
BAWUL
DIK
JSF
JSH
KQ8
RJT
RZJ
ZOHVM
ID FETCH-LOGICAL-j146n-4da65fb7c5d29639603a378300a98e857599ee464b9737a22c8c5f92430b99e3
ISSN 0009-3165
IngestDate Thu Aug 17 20:28:28 EDT 2023
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Issue Supplement1
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j146n-4da65fb7c5d29639603a378300a98e857599ee464b9737a22c8c5f92430b99e3
OpenAccessLink https://www.jstage.jst.go.jp/article/chemotherapy1953/41/Supplement1/41_Supplement1_589/_article/-char/en
PageCount 5
ParticipantIDs jstage_primary_article_chemotherapy1953_41_Supplement1_41_Supplement1_589_article_char_en
PublicationCentury 1900
PublicationDate 1993/06/30
PublicationDateYYYYMMDD 1993-06-30
PublicationDate_xml – month: 06
  year: 1993
  text: 1993/06/30
  day: 30
PublicationDecade 1990
PublicationTitle CHEMOTHERAPY
PublicationTitleAlternate Chemother.
PublicationYear 1993
Publisher Japanese Society of Chemotherapy
Publisher_xml – name: Japanese Society of Chemotherapy
References 9) 松田静治, 鈴木正明, 王欣暉, 二宮敬宇: NY-198の産婦人科領域における基礎的・臨床的検討. Chemotherapy 36 (S-2): 1085-1090, 1988
1) 久保田忠俊, 石倉公二, 南恭二, 元川清治, 中清水弘. 田中守, 三市能之, 羽島誠: 新経口セフェムS-1108および関連化合物の合成と構造活性相関. 日本薬学会第111年会, 東京, 1991
7) 松田静治, 他 (8施設): 産婦人科領域におけるCS-807の臨床応用. Chemotherapy 36 (S-1): 907-917, 1988
3) Yoshida T, Hamashima T, Komatsu Y, Nomura K, Kuwahara S: 5-1108, a New Oral Cephem: Antibacterial activity. 29th ICAAC, Abstr. No.368, Houston, Sep, 17-20, 1989
4) Yokota T, Arai K: S-1108: Antibacterial activity, stability to β-lactamase, affinity to bacterial penicillin-binding proteins, and synergy of bactericidal effect with serum complement or mousecultured macrophage of its active form, S-1006. 30 th ICAAC, Abstr. No.656, Atlanta, Oct. 21-24, 1990
8) 松田静治, 鈴木正明, 王欣暉: 産婦人科領域におけるCefdinirの臨床応用. Chemotherapy 37 (S-2): 915-921, 1989
10) 松田静治, 鈴木正明, 宮崎亮一郎, 王欣曜: 塵婦人科領域におけるT-3262の臨床応用. Chemotherapy 36 (S-9): 1209-1213, 1988
5) 由良二郎, 齋藤篤: 第40回日本化学療法学会総会, 新薬シンポジウム. S-1108, 名古屋, 1992
2) Nakashima M, Matsuno S, Yoshida T, Kimura Y, Oguma, Ishi H: Pharmacokinetics and safety of S-1108 in healthy volunteers, 29th ICAAC, Abstr. No.370, Houston, Sep. 17-20, 1989
6) 松田静治, 柏倉高, 鈴木正明: T-2588の産婦人科領域における臨床応用. Chemotherapy 34 (S-2): 850-853, 1986
References_xml
SSID ssib001106282
ssj0000626693
ssib031782880
ssib005879733
ssib008506721
Score 1.2859741
Snippet Basic and clinical studies were performed, and the following results were obtained. S-1108, a new oral cephem antibiotic, was evaluated for its tissue...
SourceID jstage
SourceType Publisher
StartPage 589
Title Basic and clinical studies of S-1108 in the field of obstetrics and gynecology
URI https://www.jstage.jst.go.jp/article/chemotherapy1953/41/Supplement1/41_Supplement1_589/_article/-char/en
Volume 41
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX CHEMOTHERAPY, 1993/06/30, Vol.41(Supplement1), pp.589-593
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6FIiEuFQgQ0FLtgSMOfuza3mNBqSKqlFeQyslar9cokeqgNDmkf40_x7cPP1o4FAQXy1lnx1nPl9nZ9cx8hLysE80zwbHI0TILWBkZNsCUByzKckBIZKUw-c6zs3T6hb075-ej0Y9B1NJ2U47V1W_zSv5Gq2iDXk2W7B9othOKBpxDvzhCwzjeSsdv5KUvt9onOLq4QJuLEpjg-zaQ0YaqmeZVCcWauvyuOvO3XaNVv7feFi2YTmbv59PJp-MPna87k5vLbWWdzc96sVx0-7N2Z-bUkDD0G9lruZMX9rs4X0l_qfL5dkkbC9eafkzZhgqzCyK1QSL6wqeH7a7ZVgGL7pgfxtqZ0zxnAc8djXFrb12hK48ry11qN0KjgRnljlbIz8jccSj-auzhvkFFavBzzEvBMYvGA7FFJ-xaWW2vtOJm74JFxbD3jY8QVvRd5RowvEPuxoC7iSc9_Th4BRmZ9NRBLbQ8E9nAtzalAge16eDHYfHrjalzI-A7iY4J0DzZe-RVO-7Xtxg1nKollhhteKL1mOYPyL5f6tBjN46HZLSUj8iZxSwF8miLWeoxS1c1dZili4biptRi1jT3mLU9e8w-JvOTyfztNPCcHsESc3ITsEqmvC4zxasYth_r50QmMAthKEWuLV2s0JqlrMTDymQcq1zxWsQsCUtcSZ6QvWbV6KeEilBmXDORMKWYUFpoSJER-qahqmrxjHx1oy--u7otxb9T-fP_KPuA3O__h4dkb7Pe6hdwfDflkQXYT8Cis5o
link.rule.ids 315,786,790,27955,27956
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Basic+and+clinical+studies+of+S-1108+in+the+field+of+obstetrics+and+gynecology&rft.jtitle=CHEMOTHERAPY&rft.au=Matsuda%2C+Seiji&rft.au=Oh%2C+Kinki&rft.au=Hirayama%2C+Hiroaki&rft.date=1993-06-30&rft.pub=Japanese+Society+of+Chemotherapy&rft.issn=0009-3165&rft.eissn=1884-5894&rft.volume=41&rft.issue=Supplement1&rft.spage=589&rft.epage=593&rft_id=info:doi/10.11250%2Fchemotherapy1953.41.Supplement1_589&rft.externalDocID=article_chemotherapy1953_41_Supplement1_41_Supplement1_589_article_char_en
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-3165&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-3165&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-3165&client=summon